Celeris Therapeutics GmbH Press Releases

• Published on January 12, 2024 - 10:00 GMT

  Celeris Therapeutics Welcomes Dr. John Harling, a Pioneer in PROTACs and TPD, as Chair of its Scientific Advisory Board

  LONDON, UK, January 12, 2024 /⁨EINPresswire.com⁩/ -- Celeris Therapeutics, a trailblazer in AI-driven drug discovery, is elated to announce the appointment of Dr. John Harling as the Chair of its Scientific Advisory Board. A luminary in the pharmaceutical …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on September 15, 2023 - 09:03 GMT

  Celeris Therapeutics Appoints James Field as Board Director, Bringing Expertise in TechBio Scaling, Robotics, and AI

  LONDON, UK, September 15, 2023 /⁨EINPresswire.com⁩/ -- Celeris Therapeutics, the pioneer in AI-driven degrader discovery, is excited to announce the appointment of James Field as a Board Director. With a proven track record in scaling up TechBio companies …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
• Published on September 4, 2023 - 09:45 GMT

  Dr. Chris Tame Joins Celeris Therapeutics as VP, Head of Drug Discovery

  Celeris Therapeutics, the PIC™ Engineering Company, Commits to Advancing Drug Discovery with the Appointment of Dr. Chris Tame as VP, Drug Discovery LONDON, UK, September 4, 2023 /⁨EINPresswire.com⁩/ -- Celeris Therapeutics, a pioneering therapeutics …

  Distribution channels: Business & Economy, Chemical Industry ...